Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26493647.
- Also identified by DOI 10.1038/nrc4019 and PMC identifier 4892184.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
High-grade serous ovarian cancer (HGSOC) accounts for 70-80% of ovarian cancer deaths, and overall survival has not changed significantly for several decades. In this Opinion article, we outline a set of research priorities that we believe will reduce incidence and improve outcomes for women with this disease. This 'roadmap' for HGSOC was determined after extensive discussions at an Ovarian Cancer Action meeting in January 2015.
Medical subject headings
- Cystadenocarcinoma, Serous
- Ovarian Neoplasms